Doximity's stock plummeted 5.02% during intraday trading on Thursday, as investors reacted to the company's upcoming quarterly earnings report.
The healthcare technology company is scheduled to report its third-quarter earnings after market close, with analysts expecting earnings per share of $0.45 according to FactSet estimates. The pre-earnings selloff suggests investor caution ahead of the financial results announcement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.